A group of 300 institutional investors, including many with ties to religious organizations, is waging a new campaign to press drugmakers to justify their price increases.
WSJ.com: US Business, Wall Street Journal: Business
Mon, 10/24/2016 - 7:26am
A group of 300 institutional investors, including many with ties to religious organizations, is waging a new campaign to press drugmakers to justify their price increases.